Phase-3 trial of Bharat Biotech's Covaxin commences in AIIMS

Dr Srivastava was the first one to receive the shot, which would be given to around 15,000 volunteers at the AIIMS over the next few days, sources said.

Source: The Economic Times - November 26, 2020 Category: Consumer Health News Source Type: news